Monsanto Company Profile (NYSE:MON)

About Monsanto

Monsanto logoMonsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Agricultural Chemicals
  • Sub-Industry: Fertilizers & Agricultural Chemicals
  • Exchange: NYSE
  • Symbol: MON
  • CUSIP: 61166W10
Key Metrics:
  • Previous Close: $102.00
  • 50 Day Moving Average: $103.57
  • 200 Day Moving Average: $102.60
  • 52-Week Range: $83.73 - $114.26
  • Trailing P/E Ratio: 33.91
  • Foreward P/E Ratio: 19.39
  • P/E Growth: 2.70
  • Market Cap: $44.37B
  • Outstanding Shares: 437,982,000
  • Beta: 1.19
  • Net Margins: 9.89%
  • Return on Equity: 46.07%
  • Return on Assets: 9.89%
  • Debt-to-Equity Ratio: 1.64%
  • Current Ratio: 1.21%
  • Quick Ratio: 0.73%
Additional Links:
Companies Related to Monsanto:

Analyst Ratings

Consensus Ratings for Monsanto (NYSE:MON) (?)
Ratings Breakdown: 2 Sell Ratings, 7 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.52)
Consensus Price Target: $114.22 (11.98% upside)

Analysts' Ratings History for Monsanto (NYSE:MON)
DateFirmActionRatingPrice TargetDetails
10/9/2016ArgusReiterated RatingBuy$128.00View Rating Details
10/8/2016BMO Capital MarketsReiterated RatingOutperform$128.00View Rating Details
10/6/2016JPMorgan Chase & Co.Set Price TargetBuy$128.00View Rating Details
10/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
10/6/2016Barclays PLCReiterated RatingHold$110.00View Rating Details
10/3/2016Monness Crespi & HardtLower Price TargetBuy$130.00 -> $128.00View Rating Details
9/27/2016Goldman Sachs Group Inc.UpgradeSell -> Neutral$104.00View Rating Details
9/26/2016Sanford C. BernsteinUpgradeUnderperform -> Market Perform$82.81 -> $105.00View Rating Details
9/15/2016Piper Jaffray Cos.Set Price TargetBuy$128.00View Rating Details
9/15/2016S&P Equity ResearchReiterated RatingPositiveView Rating Details
9/15/2016Credit Agricole SADowngradeBuy -> Underperform$110.00View Rating Details
9/6/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/19/2016Citigroup Inc.Boost Price TargetNeutral$112.00 -> $116.00View Rating Details
5/27/2016Atlantic SecuritiesDowngradeOverweight -> Neutral$109.62 -> $105.00View Rating Details
5/25/2016MacquarieSet Price TargetBuy$110.00View Rating Details
5/24/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
5/23/2016Vertical ResearchUpgradeHold -> BuyView Rating Details
5/13/2016Berenberg BankSet Price TargetBuy$110.00View Rating Details
4/12/2016SusquehannaLower Price TargetPositive$105.00 -> $101.00View Rating Details
4/9/2016Morgan StanleyReiterated RatingBuyView Rating Details
4/7/2016Bank of America Corp.Reiterated RatingSell$88.00View Rating Details
3/3/2016Vertical GroupDowngradeBuy -> HoldView Rating Details
3/2/2016Credit Suisse Group AGLower Price TargetOutperform$109.00 -> $97.00View Rating Details
10/9/2015Stifel NicolausLower Price TargetBuy$135.00 -> $115.00View Rating Details
8/24/2015Canaccord GenuityReiterated RatingBuy$134.00 -> $126.00View Rating Details
5/6/2015BB&T Corp.Initiated CoverageHold -> HoldView Rating Details
1/20/2015Topeka Capital MarketsReiterated RatingHold$111.00View Rating Details
1/2/2015Miller TabakDowngradeBuy -> NeutralView Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Monsanto (NYSE:MON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/5/2016Q416($0.02)$0.07$2.38 billion$2.56 billionViewListenView Earnings Details
6/29/2016Q316$2.40$2.17$4.49 billion$4.19 billionViewListenView Earnings Details
4/6/2016Q216$2.44$2.42$4.81 billion$4.53 billionViewN/AView Earnings Details
1/6/2016Q116($0.22)($0.11)$2.41 billion$2.22 billionViewListenView Earnings Details
10/7/2015Q415($0.02)($0.19)$2.79 billion$2.36 billionViewListenView Earnings Details
6/24/2015Q315$2.06$2.39$4.58 billionViewListenView Earnings Details
4/1/2015Q215$2.93$2.90$5.58 billion$5.20 billionViewListenView Earnings Details
1/7/2015Q115$0.35$0.47$2.80 billion$2.87 billionViewListenView Earnings Details
10/8/2014Q414($0.23)($0.27)$2.41 billion$2.63 billionViewListenView Earnings Details
6/25/2014Q314$1.56$1.62$4.41 billion$4.25 billionViewListenView Earnings Details
4/2/2014Q214$3.08$3.15$5.81 billion$5.83 billionViewListenView Earnings Details
1/8/2014Q1$0.64$0.67$3.08 billion$3.15 billionViewListenView Earnings Details
10/2/2013Q413($0.43)($0.47)$2.24 billion$2.20 billionViewListenView Earnings Details
6/26/2013Q3 2013$1.59$1.66$4.41 billion$4.25 billionViewListenView Earnings Details
4/3/2013Q2 2013$2.58$2.73$5.29 billion$5.47 billionViewN/AView Earnings Details
1/8/2013Q1 2013$0.37$0.62$2.64 billion$2.93 billionViewListenView Earnings Details
10/3/2012Q412($0.43)($0.44)$2.25 billion$2.11 billionViewN/AView Earnings Details
6/27/2012$1.58$1.63ViewN/AView Earnings Details
4/4/2012$2.11$2.28ViewN/AView Earnings Details
1/5/2012$0.17$0.23ViewN/AView Earnings Details
10/5/2011($0.27)($0.22)ViewN/AView Earnings Details
4/6/2011$1.84$1.87ViewN/AView Earnings Details
1/6/2011$0.01$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Monsanto (NYSE:MON)
Current Year EPS Consensus Estimate: $4.72 EPS
Next Year EPS Consensus Estimate: $5.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$2.35$2.99$2.66
Q2 20163$2.29$2.73$2.50
Q3 20164($0.18)$0.15($0.02)
Q4 20162($0.08)$0.39$0.16
Q1 20172$0.04$3.57$1.81
Q2 20172$2.47$2.57$2.52
Q3 20171$2.04$2.04$2.04
Q4 20171$0.09$0.09$0.09
(Data provided by Zacks Investment Research)


Current Dividend Information for Monsanto (NYSE:MON)
Annual Dividend:$2.16
Dividend Yield:2.12%
Dividend Growth:16.40% (3 Year Average)
Payout Ratio:71.05% (Based on Trailing 12 Months of Earnings)
45.76% (Based on Current Year Consensus EPS Estimate)
41.06% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Monsanto (NYSE:MON)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Monsanto (NYSE:MON)
Insider Ownership Percentage: 0.88%
Institutional Ownership Percentage: 78.94%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2016Robert T FraleyEVPSell80,631$102.04$8,227,587.24View SEC Filing  
10/10/2016Charles S McmillanDirectorBuy3,500$103.23$361,305.00View SEC Filing  
10/10/2016Steven MizellEVPSell310$103.09$31,957.90View SEC Filing  
7/14/2016Brett D BegemannCOOSell27,980$103.62$2,899,287.60View SEC Filing  
7/13/2016Michael K SternCEOSell12,797$101.77$1,302,350.69View SEC Filing  
4/19/2016George PosteDirectorSell1,136$91.93$104,432.48View SEC Filing  
4/14/2016Steven MizellEVPSell9,500$89.06$846,070.00View SEC Filing  
4/12/2016Charles S McmillanDirectorBuy3,500$87.25$305,375.00View SEC Filing  
4/12/2016Michael J FrankVPSell2,000$87.49$174,980.00View SEC Filing  
4/11/2016Steven MizellEVPSell3,900$86.87$338,793.00View SEC Filing  
11/17/2015Kerry J. PreeteEVPSell4,667$95.62$446,258.54View SEC Filing  
10/21/2015William U ParfetDirectorSell17,000$91.16$1,549,720.00View SEC Filing  
10/13/2015Steven MizellVPSell6,100$89.40$545,340.00View SEC Filing  
4/15/2015Kerry J PreeteEVPSell27,580$119.37$3,292,224.60View SEC Filing  
4/8/2015Tom D HartleyVPSell4,600$117.91$542,386.00View SEC Filing  
2/13/2015Michael K SternCOOSell1,391$125.00$173,875.00View SEC Filing  
1/20/2015David F SnivelyEVPSell29,521$117.14$3,458,089.94View SEC Filing  
1/12/2015Steven MizellVPSell20,500$118.72$2,433,760.00View SEC Filing  
11/17/2014Nicole M RingenbergVPSell12,780$118.83$1,518,647.40View SEC Filing  
10/15/2014Robert T FraleyEVPSell10,679$107.93$1,152,584.47View SEC Filing  
10/14/2014Nicole M RingenbergVPSell2,500$108.01$270,025.00View SEC Filing  
10/13/2014Steven MizellVPSell3,480$106.08$369,158.40View SEC Filing  
9/3/2014Kerry J PreeteEVPSell3,827$115.50$442,018.50View SEC Filing  
7/8/2014Michael J FrankVPSell7,500$124.53$933,975.00View SEC Filing  
7/7/2014Robert T FraleyEVPSell54,740$125.32$6,860,016.80View SEC Filing  
7/3/2014David F SnivelyEVPSell35,220$126.25$4,446,525.00View SEC Filing  
7/3/2014William U ParfetDirectorSell23,800$126.52$3,011,176.00View SEC Filing  
5/23/2014Janet M HollowaySVPSell21,280$120.00$2,553,600.00View SEC Filing  
5/7/2014Kerry PreeteEVPSell49,850$115.00$5,732,750.00View SEC Filing  
4/15/2014Hugh GrantCEOSell95,000$110.33$10,481,350.00View SEC Filing  
4/15/2014Tom HartleyVPSell7,900$110.51$873,029.00View SEC Filing  
1/17/2014Hugh GrantCEOSell44,179$112.69$4,978,531.51View SEC Filing  
1/16/2014Robert FraleyEVPSell64,850$112.57$7,300,164.50View SEC Filing  
1/14/2014Steven MizellVPSell24,000$112.05$2,689,200.00View SEC Filing  
11/11/2013Nicole RingenbergVPSell13,560$107.04$1,451,462.40View SEC Filing  
10/15/2013Tom HartleyVPSell5,860$105.70$619,402.00View SEC Filing  
10/8/2013Steven MizellVPSell11,370$104.50$1,188,165.00View SEC Filing  
10/7/2013Nicole RingenbergVPSell3,500$105.02$367,570.00View SEC Filing  
9/4/2013Kerry PreeteEVPSell5,276$99.00$522,324.00View SEC Filing  
7/19/2013Gerald A SteinerEVPSell12,293$104.00$1,278,472.00View SEC Filing  
7/9/2013Tom D HartleyVPSell6,000$100.15$600,900.00View SEC Filing  
7/8/2013Janet M HollowaySVPSell10,700$98.80$1,057,160.00View SEC Filing  
7/3/2013Hugh GrantCEOSell40,000$97.74$3,909,600.00View SEC Filing  
7/2/2013Steven MizellVPSell37,000$97.71$3,615,270.00View SEC Filing  
5/13/2013David F SnivelyEVPSell106,366$107.24$11,406,689.84View SEC Filing  
5/1/2013Pierre CourdurouxCFOSell5,720$105.47$603,288.40View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Monsanto (NYSE:MON)
News IconNestlé Shocks Monsanto with Non-GMO Product Push over Consumer Demand (NYSE:MON) - October 25 at 11:18 AM
News IconAgrochemicals and the Cesspool of Corruption: Dr. Mason Writes to the US EPA (NYSE:MON) - October 25 at 11:18 AM
News IconMonsanto Loses GMO Permit In Mexico (NYSE:MON) - October 25 at 11:18 AM
News IconSoylent food bars 'proudly made with GMOs' causing stomach problems, vomiting and diarrhea (NYSE:MON) - October 25 at 11:18 AM logoDon't Like Monsanto? Then You Should Be Pro-GMO, Not Anti. Here's Why. (NYSE:MON) - October 25 at 11:18 AM logoChemChina ready for concessions to clinch delayed Syngenta deal in 2017-source (NYSE:MON) - October 25 at 11:18 AM logoChemChina ready for concessions to clinch delayed Syngenta deal in 2017 - source (NYSE:MON) - October 25 at 11:18 AM logoIf Monsanto Loses Its Name, What Will Its Haters Have Left to Hate? (NYSE:MON) - October 25 at 11:18 AM
News IconSeriously Eye-Opening New Info About Cancer (NYSE:MON) - October 24 at 5:57 PM
News IconMonsanto Roundup Non-Hodgkins Lymphoma Cancer Lawsuits (NYSE:MON) - October 24 at 5:57 PM
News IconEffects of green snap showing up in corn fields (NYSE:MON) - October 24 at 5:57 PM logoBRIEF-Monsanto Co reaffirms company's fiscal year 2017 guidance (NYSE:MON) - October 24 at 5:56 PM logoMONSANTO CO /NEW/ Files SEC form 8-K, Regulation FD Disclosure (NYSE:MON) - October 24 at 5:56 PM logoDon't Succumb to the Buzz of the Mega Merger (NYSE:MON) - October 24 at 11:38 AM logoWhat Should Antitrust Look Like In A World Of Low Entry Barriers (NYSE:MON) - October 24 at 11:38 AM
News IconFederal Lawsuit Forces US Government To Share Disturbing Facts On Genetically Engineered Foods (NYSE:MON) - October 24 at 11:38 AM
News IconStarbucks’ Dirty Little Secret – You’ll Never Want to Go There Again (NYSE:MON) - October 24 at 11:38 AM
News IconMonsanto marijuana legalization hoax debunked (NYSE:MON) - October 24 at 11:38 AM logoThe Corporate Confidence of the AT&T-Time Warner Deal (NYSE:MON) - October 23 at 5:59 PM
News IconIn Vietnam, Agent Orange victims struggle to survive as Monsanto thrives (NYSE:MON) - October 23 at 5:59 PM
News Icon“An Attack on Us, Our Planet and Democracy:” International Report Exposes Monsanto “Vast” Monsanto Lobbying Schemes (NYSE:MON) - October 23 at 5:59 PM
News IconMonsanto Tribunal – Letter from The Hague: The Long March | Ronnie Cummins – Organic Consumers (NYSE:MON) - October 23 at 5:59 PM
News IconWhole Foods in deep financial trouble; sales plummet following deceptive anti-labeling position with Monsanto (NYSE:MON) - October 23 at 10:31 AM
News IconEPA Scientific Advisory Panel on glyphosate postponed (NYSE:MON) - October 23 at 10:31 AM
News IconInterview: Monsanto boss on sustainable maize for Africa (NYSE:MON) - October 23 at 10:31 AM logoMonsanto Talked to Three Other Companies Before Bayer Deal (2) (NYSE:MON) - October 23 at 10:31 AM
News IconMonsanto Faces Tribunal for Crimes Against Humanity (NYSE:MON) - October 23 at 10:31 AM
News IconEPA Succumbs to Pressure From Monsanto, Delays Glyphosate Cancer Review (NYSE:MON) - October 22 at 5:48 PM
News IconMore lawsuits agaist Monsanto stemming from cancer causing ingredients in its agriculture products (NYSE:MON) - October 22 at 5:48 PM
News IconBayer Monsanto Merger Will Steal The Marijuana Industry (NYSE:MON) - October 22 at 5:48 PM
News IconMonsanto Tribunal: “Empowered Victims” (NYSE:MON) - October 22 at 5:48 PM
News IconConcert Wealth Management Inc. Acquires 2575 Shares of Monsanto Co. (MON) - DailyQuint (NYSE:MON) - October 21 at 6:14 PM logoMonsanto Co. : MON-US: Dividend Analysis : October 07th, 2016 (record date) : By the numbers : October 21, 2016 (NYSE:MON) - October 21 at 6:14 PM logoMorgan Stanley to see $120 million fee from Monsanto-Bayer deal - St. Louis Business Journal (NYSE:MON) - October 21 at 9:38 AM logoA Rebound in Defensive Stocks? Banish the Thought (NYSE:MON) - October 21 at 9:38 AM
News IconHow Will The Monsanto-Bayer Merger Affect Everyday Farmers? (NYSE:MON) - October 20 at 6:34 PM logoMonsanto talked to three other suitors before Bayer (NYSE:MON) - October 20 at 6:34 PM logoComing Soon To A Vineyard Near You: GMO (NYSE:MON) - October 20 at 6:34 PM logo[$$] Morgan Stanley in line for record $120m fee from Monsanto (NYSE:MON) - October 20 at 6:34 PM logoMorgan Stanley in Line for $120 Million Payday in Bayer-Monsanto Deal (NYSE:MON) - October 20 at 6:34 PM logoForm 4 MONSANTO CO /NEW/ For: Oct 17 Filed by: GRANT HUGH - (NYSE:MON) - October 20 at 11:55 AM logoMonsanto talked to three other suitors before Bayer - St. Louis Business Journal (NYSE:MON) - October 20 at 11:55 AM
News IconFiling Analysis: Monsanto Co New (Call) (MON) Stock Value Rose While Jefferies Group LLC Has Lowered Its Position - Chester News (NYSE:MON) - October 20 at 11:55 AM logoMonsanto Talked to Three Other Companies Before Bayer Deal ... - Bloomberg (NYSE:MON) - October 20 at 11:55 AM logoBear of the Day: Monsanto Company (MON) (NYSE:MON) - October 20 at 11:55 AM
News IconNot Healthy After All? Customers Say Pro-GMO “Soylent” Food Bars Made Them Violently Ill (NYSE:MON) - October 19 at 6:32 PM logoEPA Bows to Chemical Industry in Delay of Glyphosate Cancer Review (NYSE:MON) - October 19 at 6:32 PM
News IconIs Monsanto Going After The Marijuana Industry (NYSE:MON) - October 19 at 6:32 PM logoMONSANTO CO /NEW/ Files SEC form 10-K, Annual Report (NYSE:MON) - October 19 at 6:32 PM logoCramer: Worried about your money under a Democratic landslide? You should be (NYSE:MON) - October 19 at 6:32 PM


Monsanto (NYSE:MON) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff